APhA: The status of DIR fees: Your questions answered

Feb 26, 2020

It’s been a stop-and-go journey toward the elimination of the retroactive direct and indirect remuneration (DIR) fees that are causing intense turmoil in the pharmacy community, particularly in the independent pharmacy space. APhA Senior Lobbyist Alicia Kerry Mica, a key player in the coalition of pharmacy stakeholders working to end abusive PBM practices, sat down with Pharmacy Today to share the good, the bad, and the ugly in the fight to end DIR fees.

Originally published "Pharmacy Today" (2020, January.)  Read the full article here.